LI Na

Title：Professor

Specialties：Microbiology and Immunology

Email：vetlina2013@126.com

Li Na obtained her bachelor degree in Veterinary Medicine from Hunan Agriculture University in 2011. After obtaining her master degree at Jilin University in 2014, she started her PhD trajectory at Leiden University Medical Center in the Netherlands under the supervision of Prof. Frits Koning and investigated the human immune system development using high-dimensional single-cell technologies. In 2019, she obtained her PhD degree in Medicine with distinction “Cum Laude” (Top 5%) from Leiden University. In 2020, she went back to the College of Veterinary Medicine at Jilin University. She mainly focuses on the immunology and bioinformation and has several publications on Nature Immunology (cover), Journal of Experimental Medicine (cover) and Immunity.

Research Interests：                        

· Infection and Immunology

·Pathogenic mechanism and control and prevention of important zoonosis

Selected Publications：

1. A validated 34-marker panel for Imaging Mass Cytometric analysis of human snap-frozen tissue. Frontiers in Immunology. 2020. 11: 1466. Corresponding author. (IF =5.08)

2. (Cover, ESI highly-cited paper, Top1%) Memory CD4⁺ T cells are generated in the human fetal intestine. Nature Immunology. 2019. 20(3) 301-312. First author. (IF=23.53)

3. Early-Life Compartmentalization of Immune Cells in Human Fetal Tissues Revealed by High-Dimensional Mass Cytometry. Frontiers in Immunology. 2019. 10(5) 1383-1396. First author. (IF=5.08)

4. (Cover) Mass cytometry reveals innate lymphoid cell differentiation pathways in the human fetal intestine. Journal of Experimental Medicine. 2018. 215(5) 1383-1396. First author. (IF=10.89)

5. (ESI highly-cited paper, Top1%) β-Hydroxybutyrate induces bovine hepatocyte apoptosis via an ROS-p38 signaling pathway. Journal of Dairy Science. 2016. 99(11) 9184-9198. Co-first author. (IF=3.08)

Awards：

1. The First-grade Prize for “DIRK BARTZ PRIZE FOR VISUAL COMPUTING IN MEDICINE” in 2019.

2. PhD degree with distinction “Cum laude” (Top 5%).